DSM Investor Relations by DSM Group Business Services B.V.
Teva's Great Dividend Yield (NYSE:TEVA) | Seeking Alpha
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
DEF 14A
MedinCell's Partner Teva Today Announced Refiling for Approval of mdc-IRM and Confirmed Planned Launch in the U.S. in H1 2023
Ran Meir - SVP - Investor Relations & Corporate Communications - Teva Pharmaceuticals | LinkedIn
Full Year 2010 Earnings
Teva Announces New Organization Structure and Leadership Changes | Business Wire
Website: www.tevapharm.com For Immediate Release Teva Reports 2007 Financials in XBRL Standard Intended to Facilitate Investor
Alvotech to Participate in Jefferies Healthcare Conference
TEVA REPORTS RECORD SALES AND NET INCOME IN Q2 • Net Sales reach $1.2 billion, Net Income $230 million, and EPS $0.35 • Sec
Shiri Sommer - Investor Relations Manager - MAOZ מעוז | LinkedIn
Teva Pharmaceutical Industries Ltd. Protalix Ltd. Web Site: www.tevapharm.com Web Site: www.protalix.com
DEF 14A
Teva to Launch New Growth Strategy at Investor Day | Business Wire
Teva buying Cephalon for $6.8 billion - cleveland.com
Teva: Great Investment With An Upside Even In Volatile Markets (NYSE:TEVA) | Seeking Alpha
Elana Holzman - Head of Investor Relations - ZIM Integrated Shipping Services | LinkedIn
Investor Relations Program
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call Transcript
Teva Pharmaceuticals Director of Investor Relations Salaries in Boulder | Comparably
Investor Relations Officer
Ex-Teva Chairman, Blockchain Investor Accused of Pump-and-Dump Scheme - WSJ
American Creek Resources Ltd. - Investor Relations
